Utilization of Oncotype DX in an Inner City Population: Race or Place?

Oncotype DX, a 21-gene-array analysis, can guide chemotherapy treatment decisions for women with ER+ tumors. Of 225 ER+ women participating in a patient assistance trial, 23% underwent Oncotype DX testing: 31% of whites, 21% of blacks, and 14% of Hispanics (P=0.04) were tested. Only 3 white wome...

Full description

Saved in:
Bibliographic Details
Main Authors: Amber A. Guth, Susan Fineberg, Kezhen Fei, Rebeca Franco, Nina A. Bickell
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2013/653805
Tags: Add Tag
No Tags, Be the first to tag this record!